
April 17, 2026
New Study Finds Weight Loss Causes Significant Muscle Loss
UNC research advises physicians carefully evaluate how much muscle composition patients lose while taking popular drugs for weight loss.

April 17, 2026
UNC research advises physicians carefully evaluate how much muscle composition patients lose while taking popular drugs for weight loss.

June 23, 2025
Co-led by UNC School of Medicine’s John Buse, MD, PhD, researchers discover how treatment of hypercortisolism could improve glucose control and promote weight loss in diabetes.

April 22, 2025
Study reveals hypercortisolism identified in 24 percent of patients with difficult-to-control type 2 diabetes. John Buse, MD, PhD, director of UNC’s Diabetes Care Center, is lead author.

March 29, 2025
A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes, pre-existing cardiovascular disease, and/or chronic kidney disease.

February 12, 2025
Researchers at the UNC School of Medicine have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
February 12, 2025
Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

October 23, 2024
Nina Jain, MD, MBA, professor of pediatric endocrinology, and Ali Calikoglu, MD, retired professor of pediatrics, both at the UNC School of Medicine, played a pivotal role in getting this therapy to the bedside, from assisting with clinical trials to the infusion of the first pediatric patient in North Carolina at UNC Children’s.
May 15, 2024
Brooke Matson, Jeremy Meier, Brittany Raffa, and Shivani Sud will receive support from the UNC School of Medicine Physician Scientists Training Program to cultivate their careers as translational clinical scientists.

February 26, 2024
A research study named Early Check has screened 1,000 newborns after birth in an effort to help identify rare conditions early, provide treatment, give parents educational information, and connect families with specialists throughout the state of North Carolina.

July 11, 2023
Springer recently released "Chronic Illness Care, Principles and Practice," edited by UNC Family Medicine's Timothy P. Daaleman, DO, MPH, and Margaret R. Helton, MD. Faculty members in the Department of Family Medicine, faculty across the UNC-Chapel Hill campus, and other national and international experts wrote the textbook.

June 26, 2023
A multicenter, randomized, phase 3b trial, done in collaboration with a UNC School of Medicine researcher, found that once-daily oral semaglutide taken at higher doses of 25mg and 50mg improved regulation of blood sugar levels and weight loss compared to the standard 14 mg dose.

March 20, 2023
The study, which was conducted at UNC-Chapel Hill between 2016 and 2022, concluded that metformin use did not reduce risks for adverse neonatal outcomes in pregnancies with type 2 diabetes. The study findings were reported at the annual meeting of the Society for Maternal Fetal Medicine in February.